The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
so the question is are there trials happening where people are exploring say psilocybin MDMA which by the way we know increases oxytocin and serotonin dramatically as well as um things like atypical anti-depressants in kids that have autism not because we think that those autistic kids are deficient in any of the neurochemical that these drugs would Target but that these drugs can help rewire the brain and ultimately that's what these kids need right
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.